Treatment of the Psychiatric Manifestations of Huntington's Disease: A Review of the Literature

Abstract

French

Objective:

To review the clinical management of the psychiatric aspects of Huntington's disease (HD), namely the mood disorders, psychotic disorders, anxiety symptoms, sleep disorders, disorders of sexuality, and the behavioural changes of apathy, irritability, and aggression. Emphasis is on pharmacologic and psychotherapeutic intervention strategies. In addition, the role of psychiatric intervention in presymptomatic testing is explored.

Method:

English language literature on the pharmacologic and psychotherapeutic management of the psychiatric manifestations of HD between 1976 and 1996 was critically reviewed.

Results:

Few sound studies address the clinical management of the psychiatric aspects of HD; thus, only the broadest conclusions can be drawn. Pharmacologic strategies for the treatment of psychiatric aspects of HD were organized according to the therapeutic agent and class, and psychotherapeutic strategies were discussed.

Conclusion:

The clinical management of the psychiatric manifestations of HD requires much more complete and systematic study before any definite conclusions as to efficacy of various approaches can be drawn.

Keywords

Huntington's disease psychiatric treatment

References

Folstein

Chase

Wahl

McDonnell

Folstein

. Huntington's disease in Maryland: Clinical aspects of racial variation. Am J Hum Genet 1987;41:168–79.

Shokeir

MHK

. Investigations on Huntington's disease in the Canadian prairies. I Prevalence. Clin Genet 1975;7:345–8.

Farrer

Cupples

Winter

Conneally

Gusella

Myers

. The normal Huntington's disease (HD) allele, or a closely linked gene influences age of onset of HD. Am J Hum Genet 1993;53:125–30.

Harper

. Huntington's disease. Philadelphia: WB Saunders; 1991. p 1–15.

Bird

Caro

Pilling

. A sex related factor in the inheritance of Huntington's chorea. Ann Hum Genet 1974;37:255–60.

Lanska

Lavine

Schoenberg

. Conditions associated with Huntington's disease at death, a case-control study. Arch Neurol 1988;45:878–80.

Morris

. Psychiatric aspects of Huntington's disease. In: Harper

, editor. Huntington's disease. Philadelphia: WB Saunders; 1991. p 81–126.

Dewhurst

Oliver

McKnight

. Socio-psychiatric consequences of Huntington's disease. Br J Psychiatry 1970;116:255–8.

Gusella

Wexler

Conneally

Naylor

Anderson

, Tanzi RE, and others. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234–8.

10.

Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971–83.

11.

Simpson

Harding

. Predictive testing for Huntington's disease: After the gene. J Med Genet 1993;30:1036–8.

12.

de la Monte

Vonsattel

Richardson

. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516–25.

13.

Martin

Gusella

. Huntington's disease: Pathogenesis and management. N Engl J Med 1986;20:1267–76.

14.

Young

Shoulson

Penney

Starosta-Rubinstein

Gomez

, Travers H, and others. Huntington's disease in Venezuela: Neurological features and functional decline. Neurology 1986;36:244–9.

15.

Koller

Trimble

. The gait abnormality of Huntington's disease. Neurology 1985;35:1450–4.

16.

McHugh

Folstein

. Psychiatric syndromes of Huntington's chorea: A clinical and phenomenologic study. In: Benson

DDF

Blumer

, editors. Psychiatric aspects of neurologic disease. New York: Grune & Stratton; 1975. p 267–86.

17.

Folstein

. Huntington's disease: A disorder of families. Baltimore (MD): Johns Hopkins University Press; 1989.

18.

Folstein

Franz

Jensen

B A

Chase

Folstein

. Conduct disorder and affective disorder amony the offspring of patients with Huntington's disease. Psychol Med 1983;13:45–52.

19.

Schoenfeld

Myers

Cupples

Barkman

Sax

Clark

. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1984;47:1283–7.

20.

Mendez

. Huntington's disease: Update and review of neuropsychiatrie aspects. Int J Psychiatry Med 1994;24:189–208.

21.

Vestergaaid

Baastmp

Peterson

. Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial. Acta Psychiatr Scand 1977;56:183–8.

22.

Shoulson

. Huntington disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981;31:1333–5.

23.

Whittier

Heimler

Korenyi

. The psychiatrist and Huntington's disease. Am J Psychiatry 1972;128:1546–50.

24.

Caine

Shoulson

. Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983;140:728–33.

25.

Ranen

Peyser

Folstein

. ECT as a treatment for depression in Huntington's disease. J Neuropsych 1994;6:154–8.

26.

Figiel

Krishna

Doraiswamy

. Subcortical structural change in ECT-induced delirium. J Geriatr Psychiatry Neurol 1990;3:172–6.

27.

Peyser

Folstein

. Depression in Huntington's disease. In: Starkstein

Robinson

, editors. Depression in neurologic disease. Baltimore (MD): Johns Hopkins University Press; 1993. p 117–39.

28.

Morris

. Psychiatric aspects of Huntington's disease. In: Harper

, editor. Huntington's disease: Major problems in neurology. London: Saunders; 1991. p 81–126.

29.

Bolt

JMW

. Huntington's chorea in the west of Scotland. Br J Psychiatry 1970;116:259–70.

30.

Cummings

. Behavioral and pscyhiatric symptoms associated with HD. In: Weiner

Lang

, editors. Advances in neurology. Volume 65. New York: Raven Press; 1995. p 179–86.

31.

Folstein

McHugh

. Psychiatric syndromes in Huntington's disease. In: Chase TN, and others, editors. Advances in neurology. Volume 23. New York: Raven Press; 1979. p 281–9.

32.

Sajatovic

Verbanac

Ramirez

Meitzer

. Clozapine treatment of psychiatric syndromes resistant to neuroleptic treatment in patients with Huntington's disease. Neurology 1991;41:156.

33.

Evans

Pedersen

Tancer

. ECT in the treatment of organic psychosis in Huntington's disease. Convuls Ther 1987;3:145–50.

34.

Baxter

Mazziotta

Pahl

Grafton

St George-Hyslop

Haines

. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiatry 1992;49:148–52.

35.

Bums

Folstein

Brandt

Folstein

. Clinical assessment of irritability, aggression, and apathy in Huntington's and Alzheimer disease. J Nerv Ment Dis 1990;178:20–6.

36.

Stewart

Mounts

Clark

. Aggressive behavior in Huntington's disease: Treatment with propranolol. J Clin Psychiatry 1987;48:106–8.

37.

Stewart

. Paradoxical aggressive effect of propranolol in a patient with Huntington's disease [letter]. J Clin Psychiatry 1987;48:385–6.

38.

Van Hafften

Jensen

. Paradoxical response to pindolol treatment for aggression in a patient with Huntington's disease [letter]. J Clin Psychiatry 1989;50:230.

39.

Greendyke

Kanter

. Therapeutic effects of pindolol on behavioural disturbances associated with organic brain disease: A double-blind study. J Clin Psychiatry 1986;47:423–6.

40.

Gualtieri

. Pharmacology and the neruo-behavioural sequelae of traumatic brain injury. Brain Inj 1988;2:101–29.

41.

Mattes

. Valproic acid for nonaffective aggression in the mentally retarded. J Nerv Men Dis 1992;180:601–2.

42.

Yudovsky

Silver

Schneider

. Pharmacologic treatment of aggression. Psychiatric Annals 1987;17:397–406.

43.

Oliver

. Huntington's chorea in Northhamptonshire. Br J Psychiatry 1970;116:241–53.

44.

Fedoroff

Peyser

Franz

Folstein

. Sexual disorders in Huntington's disease. J Neuropsychiatry Clin Neurosci 1994;6:147–53.

45.

Rich

Ovsiew

. Leuprolide acetate for exhibitionism in Huntington's disease. Mov Disord 1994;9:353–7.

46.

Hansotia

Wall

Berendes

. Sleep disturbances and severity of Huntington's disease. Neurology 1985;35:1672–4.

47.

Emser

Brenner

Stober

Schimrigk

. Changes in nocturnal sleep in Huntington's and Parkinson s disease. J Neurol 1988;235:177–9.

48.

Wiegand

Moller

Lauer

Stolz

Schreiber

, Dose M, and others. Nocturnal sleep in Huntington's disease. J Neurol 1991;238:203–8.

49.

Fish

Sawyers

Allen

Blackie

Lee

Marsden

. The effect of sleep on the dyskinetic movements of Parkinson s disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia. Arch Neurol 1991;48:210–4.

50.

Bliwise

. Sleep in normal aging and dementia. Sleep 1993;16:40–81.

51.

Cummings

Cunningham

. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry 1992;31:263–70.

52.

Wexler

. Huntington's disease and other late onset genetic disorders. In: Emery

Pullen

, editors. Psychological aspects of genetic counseling. New York: Academic Press; 1984.

53.

Kessler

. Psychiatric implications of presymptomatic testing for Huntington's disease. Am J Orthopsychiatry 1987;57:212–9.

54.

Markel

Young

Penney

. At-risk perons attitudes toward presymptomatic and prenatal testing of Huntington's disease in Michigan. Am J Med Genet 1987;26:295–305.

55.

Forrest

. Psychotherapy of patients with neuropsychiatrie disorders. In: Yudovsky

Hales

, editors. The American Psychiatric Press textbook of neuropsychiatry. 2nd ed. Washington (DC): American Psychiatric Press; 1988. p 703–9.

56.

Folstein

. Genetic counseling for psychiatric disorder: Teaching consultands about genotypes and phentypes. In: Oldham

Riba

, editors. The American Psychiatric Press review of psychiatry. Volume 14. Washington (DC): American Psychiatric Press; 1995.

57.

Folstein

. Diagnosis and treatment of Huntington's disease. Compr Ther 1981;7:60–6.

58.

Folstein

Abbott

Chase

Jensen

Folstein

. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med 1983;13:537–42.

59.

Moldawsky

. Effect of amoxapine on speech in a patient with Huntington's disease [letter]. Am J Psychiatry 1984;141:150.

60.

Ford

. Treatment of depression in Huntington's disease with monoamine oxidase inhibitors. Br J Psychiatry 1986;149:654–6.

61.

Knowling

Wrench

. Treatment of Huntington's chorea with sulpiride [letter]. S Afr Med J 1991;79:169.

62.

Stewart

. Huntington's disease and propranolol. Am J Psychiatry 1993;150:166–7.

63.

Leonard

Kidson

Brown

JGE

Shannon

Taryan

. A double-blind trial of lithium carbonate and haloperidol in Huntington's chorea. Aust N Z J Psychiatry 1975;9:115–8.

64.

Findling

. Treatment of aggression in juvenile-onset Huntington's disease with buspirone. Psychosomatics 1993;34:460–1.

65.

Ranen

Peyser

Folstein

. A physician s guide to the management of Huntington's disease: Pharmacologic and non-pharmacologic interventions. New York: Huntington's Disease Society of America; 1993.